vs
摩凡陀集团（MOV）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是摩凡陀集团的1.1倍（$207.3M vs $186.1M），摩凡陀集团净利率更高（5.1% vs -62.0%，领先67.2%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 1.9%），摩凡陀集团自由现金流更多（$11.6M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 2.9%）
摩凡陀集团是源自瑞士的美国奢侈钟表品牌，创始于1881年，品牌名取自世界语，原意为“律动”。摩凡陀腕表以12点钟位置标志性的金属圆点设计与极简风格著称，其中博物馆腕表更是品牌最广为人知的经典代表作。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
MOV vs RARE — 直观对比
营收规模更大
RARE
是对方的1.1倍
$186.1M
营收增速更快
RARE
高出24.0%
1.9%
净利率更高
MOV
高出67.2%
-62.0%
自由现金流更多
MOV
多$112.4M
$-100.8M
两年增速更快
RARE
近两年复合增速
2.9%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $186.1M | $207.3M |
| 净利润 | $9.6M | $-128.6M |
| 毛利率 | 54.3% | — |
| 营业利润率 | 6.3% | -54.7% |
| 净利率 | 5.1% | -62.0% |
| 营收同比 | 1.9% | 25.9% |
| 净利润同比 | 89.8% | 3.5% |
| 每股收益（稀释后） | $0.42 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MOVRARE
| Q4 25 | $186.1M | $207.3M | ||
| Q3 25 | $161.8M | $159.9M | ||
| Q2 25 | $131.8M | $166.5M | ||
| Q1 25 | $181.5M | $139.3M | ||
| Q4 24 | $180.5M | $164.6M | ||
| Q3 24 | $157.0M | $139.5M | ||
| Q2 24 | $134.4M | $147.0M | ||
| Q1 24 | $175.8M | $108.8M |
净利润MOVRARE
| Q4 25 | $9.6M | $-128.6M | ||
| Q3 25 | $3.0M | $-180.4M | ||
| Q2 25 | $1.4M | $-115.0M | ||
| Q1 25 | $8.1M | $-151.1M | ||
| Q4 24 | $4.8M | $-133.2M | ||
| Q3 24 | $3.5M | $-133.5M | ||
| Q2 24 | $2.0M | $-131.6M | ||
| Q1 24 | $9.8M | $-170.7M |
毛利率MOVRARE
| Q4 25 | 54.3% | — | ||
| Q3 25 | 54.1% | — | ||
| Q2 25 | 54.1% | — | ||
| Q1 25 | 54.2% | — | ||
| Q4 24 | 53.5% | — | ||
| Q3 24 | 54.3% | — | ||
| Q2 24 | 54.3% | — | ||
| Q1 24 | 53.5% | — |
营业利润率MOVRARE
| Q4 25 | 6.3% | -54.7% | ||
| Q3 25 | 2.5% | -106.9% | ||
| Q2 25 | 0.2% | -64.8% | ||
| Q1 25 | 5.1% | -102.6% | ||
| Q4 24 | 3.3% | -74.3% | ||
| Q3 24 | 1.7% | -94.6% | ||
| Q2 24 | 1.6% | -79.1% | ||
| Q1 24 | 6.1% | -151.9% |
净利率MOVRARE
| Q4 25 | 5.1% | -62.0% | ||
| Q3 25 | 1.8% | -112.8% | ||
| Q2 25 | 1.1% | -69.0% | ||
| Q1 25 | 4.4% | -108.5% | ||
| Q4 24 | 2.7% | -80.9% | ||
| Q3 24 | 2.2% | -95.7% | ||
| Q2 24 | 1.5% | -89.5% | ||
| Q1 24 | 5.6% | -156.8% |
每股收益（稀释后）MOVRARE
| Q4 25 | $0.42 | $-1.28 | ||
| Q3 25 | $0.13 | $-1.81 | ||
| Q2 25 | $0.06 | $-1.17 | ||
| Q1 25 | $0.36 | $-1.57 | ||
| Q4 24 | $0.21 | $-1.34 | ||
| Q3 24 | $0.15 | $-1.40 | ||
| Q2 24 | $0.09 | $-1.52 | ||
| Q1 24 | $0.44 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $183.9M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $497.5M | $-80.0M |
| 总资产 | $751.9M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MOVRARE
| Q4 25 | $183.9M | $421.0M | ||
| Q3 25 | $180.5M | $202.5M | ||
| Q2 25 | $203.1M | $176.3M | ||
| Q1 25 | $208.5M | $127.1M | ||
| Q4 24 | $181.5M | $174.0M | ||
| Q3 24 | $198.3M | $150.6M | ||
| Q2 24 | $225.4M | $480.7M | ||
| Q1 24 | $262.1M | $112.3M |
股东权益MOVRARE
| Q4 25 | $497.5M | $-80.0M | ||
| Q3 25 | $489.9M | $9.2M | ||
| Q2 25 | $493.2M | $151.3M | ||
| Q1 25 | $481.3M | $144.2M | ||
| Q4 24 | $491.3M | $255.0M | ||
| Q3 24 | $492.0M | $346.8M | ||
| Q2 24 | $489.6M | $432.4M | ||
| Q1 24 | $505.9M | $140.3M |
总资产MOVRARE
| Q4 25 | $751.9M | $1.5B | ||
| Q3 25 | $748.7M | $1.2B | ||
| Q2 25 | $747.2M | $1.3B | ||
| Q1 25 | $729.2M | $1.3B | ||
| Q4 24 | $747.2M | $1.5B | ||
| Q3 24 | $742.5M | $1.5B | ||
| Q2 24 | $736.0M | $1.6B | ||
| Q1 24 | $756.5M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.3M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $11.6M | $-100.8M |
| 自由现金流率自由现金流/营收 | 6.2% | -48.6% |
| 资本支出强度资本支出/营收 | 0.4% | 0.5% |
| 现金转化率经营现金流/净利润 | 1.28× | — |
| 过去12个月自由现金流最近4个季度 | $35.3M | $-472.0M |
8季度趋势，按日历期对齐
经营现金流MOVRARE
| Q4 25 | $12.3M | $-99.8M | ||
| Q3 25 | $-3.8M | $-91.4M | ||
| Q2 25 | $-7.2M | $-108.3M | ||
| Q1 25 | $39.1M | $-166.5M | ||
| Q4 24 | $-4.7M | $-79.3M | ||
| Q3 24 | $-17.8M | $-67.0M | ||
| Q2 24 | $-18.1M | $-77.0M | ||
| Q1 24 | $69.4M | $-190.7M |
自由现金流MOVRARE
| Q4 25 | $11.6M | $-100.8M | ||
| Q3 25 | $-5.1M | $-92.7M | ||
| Q2 25 | $-8.7M | $-110.7M | ||
| Q1 25 | $37.5M | $-167.8M | ||
| Q4 24 | $-7.2M | $-79.5M | ||
| Q3 24 | $-20.1M | $-68.6M | ||
| Q2 24 | $-19.7M | $-79.0M | ||
| Q1 24 | $67.8M | $-193.9M |
自由现金流率MOVRARE
| Q4 25 | 6.2% | -48.6% | ||
| Q3 25 | -3.1% | -58.0% | ||
| Q2 25 | -6.6% | -66.5% | ||
| Q1 25 | 20.7% | -120.5% | ||
| Q4 24 | -4.0% | -48.3% | ||
| Q3 24 | -12.8% | -49.2% | ||
| Q2 24 | -14.7% | -53.7% | ||
| Q1 24 | 38.6% | -178.2% |
资本支出强度MOVRARE
| Q4 25 | 0.4% | 0.5% | ||
| Q3 25 | 0.8% | 0.8% | ||
| Q2 25 | 1.2% | 1.5% | ||
| Q1 25 | 0.9% | 1.0% | ||
| Q4 24 | 1.4% | 0.1% | ||
| Q3 24 | 1.5% | 1.2% | ||
| Q2 24 | 1.2% | 1.4% | ||
| Q1 24 | 0.9% | 3.0% |
现金转化率MOVRARE
| Q4 25 | 1.28× | — | ||
| Q3 25 | -1.27× | — | ||
| Q2 25 | -5.08× | — | ||
| Q1 25 | 4.86× | — | ||
| Q4 24 | -0.98× | — | ||
| Q3 24 | -5.14× | — | ||
| Q2 24 | -8.97× | — | ||
| Q1 24 | 7.06× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MOV
| Other | $81.4M | 44% |
| Owned Brands Category | $46.0M | 25% |
| Sales Channel Directly To Consumer | $35.3M | 19% |
| Company Stores | $23.4M | 13% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
